Maplight Therapeutics Inc (MPLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 46,729 | 38,253 |
| Marketable Securities | 258,374 | 70,542 |
| TOTAL | $324,670 | $114,602 |
| Non-Current Assets | ||
| PPE Net | 1,095 | 1,207 |
| Investments And Advances | 147,993 | 11,380 |
| Other Non-Current Assets | 5,754 | 9,727 |
| TOTAL | $154,842 | $22,314 |
| Total Assets | $479,512 | $136,916 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 3,289 | 1,912 |
| Accrued Expenses | 12,049 | 9,991 |
| TOTAL | $16,229 | $15,920 |
| Non-Current Liabilities | ||
| Deferred Revenues | N/A | 3,239 |
| Other Non-Current Liabilities | 4,911 | 5,801 |
| TOTAL | $4,911 | $5,801 |
| Total Liabilities | $21,140 | $21,721 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 42,436 | N/A |
| Common Shares | 5 | N/A |
| Retained earnings | -360,520 | -199,368 |
| Other shareholders' equity | -228 | 163 |
| TOTAL | $458,372 | $-193,628 |
| Total Liabilities And Equity | $479,512 | $-171,907 |